Management of prostate cancer patients with lymph node involvement: A rapidly evolving paradigm
- 1 December 2012
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 38 (8) , 956-967
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Practical Approach for Comparative Analysis of Multilesion Molecular Imaging Using a Semiautomated Program for PET/CTJournal of Nuclear Medicine, 2011
- Detection of Recurrent Prostate Carcinoma withanti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and111In–Capromab Pendetide SPECT/CTRadiology, 2011
- Developing imaging strategies for castration resistant prostate cancerActa Oncologica, 2011
- Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-CholineJournal of Nuclear Medicine, 2010
- Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancerRadiotherapy and Oncology, 2009
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate CancerClinical Cancer Research, 2008
- The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping StudyEuropean Urology, 2008
- Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005Urology, 2007
- Technology Insight: monoclonal antibody imaging of prostate cancerNature Reviews Endocrinology, 2006
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999